{"count": 17, "results": [{"_id": "38278349", "pmid": 38278349, "title": "Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats.", "journal": "Life Sci", "authors": ["Hasan IH", "Shaheen SY", "Alhusaini AM", "Mahmoud AM"], "date": "2024-03-01T00:00:00Z", "doi": "10.1016/j.lfs.2024.122445", "meta_date_publication": "2024 Mar 1", "meta_volume": "340", "meta_issue": "", "meta_pages": "122445", "score": 50250.85, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ effectively ameliorated @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@, @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@kidney hypertrophy@@@, body @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@, and @DISEASE_Soft_Tissue_Injuries @DISEASE_MESH:D017695 @@@tissue injury and@@@ @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ animals. ", "citations": {"NLM": "Hasan IH, Shaheen SY, Alhusaini AM, Mahmoud AM. Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats. Life Sci. 2024 Mar 1;340():122445. PMID: 38278349", "BibTeX": "@article{38278349, title={Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats.}, author={Hasan IH and Shaheen SY and Alhusaini AM and Mahmoud AM}, journal={Life Sci}, volume={340}, pages={122445}}"}}, {"_id": "37543347", "pmid": 37543347, "title": "ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver.", "journal": "Biochem Pharmacol", "authors": ["Kurosawa K", "Nakano M", "Yokoseki I", "Nagaoka M", "Takemoto S", "Sakai Y", "Kobayashi K", "Kazuki Y", "Fukami T", "Nakajima M"], "date": "2023-08-03T00:00:00Z", "doi": "10.1016/j.bcp.2023.115733", "meta_date_publication": "2023 Aug 3", "meta_volume": "215", "meta_issue": "", "meta_pages": "115733", "score": 50231.25, "text_hl": "Activation of @GENE_NR1I2 @GENE_8856 @@@PXR@@@ by drugs such as @CHEMICAL_Rifampin @CHEMICAL_MESH:D012293 @@@rifampicin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, and @CHEMICAL_efavirenz @CHEMICAL_MESH:C098320 @@@efavirenz@@@ causes adverse reactions such as drug-drug interaction, @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@, and @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@. ", "citations": {"NLM": "Kurosawa K, Nakano M, Yokoseki I, Nagaoka M, Takemoto S, Sakai Y, Kobayashi K, Kazuki Y, Fukami T, Nakajima M. ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver. Biochem Pharmacol. 2023 Aug 3;215():115733. PMID: 37543347", "BibTeX": "@article{37543347, title={ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver.}, author={Kurosawa K and Nakano M and Yokoseki I and Nagaoka M and Takemoto S and Sakai Y and Kobayashi K and Kazuki Y and Fukami T and Nakajima M}, journal={Biochem Pharmacol}, volume={215}, pages={115733}}"}}, {"_id": "18362595", "pmid": 18362595, "title": "Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism.", "journal": "Anesthesiology", "authors": ["Gu W", "Kehl F", "Krolikowski JG", "Pagel PS", "Warltier DC", "Kersten JR"], "date": "2008-04-01T00:00:00Z", "doi": "10.1097/ALN.0b013e3181672590", "meta_date_publication": "2008 Apr", "meta_volume": "108", "meta_issue": "4", "meta_pages": "634-42", "score": 50070.117, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ restores ischemic preconditioning in the presence of @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ through a @CHEMICAL_Nitric_Oxide @CHEMICAL_MESH:D009569 @@@nitric oxide@@@-mediated mechanism.", "citations": {"NLM": "Gu W, Kehl F, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism. Anesthesiology. 2008 Apr;108(4):634-42. PMID: 18362595", "BibTeX": "@article{18362595, title={Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism.}, author={Gu W and Kehl F and Krolikowski JG and Pagel PS and Warltier DC and Kersten JR}, journal={Anesthesiology}, volume={108}, number={4}, pages={634-42}}"}}, {"_id": "23761972", "pmid": 23761972, "pmcid": "PMC3673969", "title": "Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin", "journal": "Vasc Health Risk Manag", "authors": ["Steinberg H", "Anderson MS", "Musliner T", "Hanson ME", "Engel SS"], "date": "2013-01-01T00:00:00Z", "doi": "10.2147/VHRM.S44330", "meta_date_publication": "2013", "meta_volume": "9", "meta_issue": "", "meta_pages": "273-82", "score": 50069.348, "text_hl": "Management of @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ and @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ with a fixed-dose combination of @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@", "citations": {"NLM": "Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS. Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin Vasc Health Risk Manag. 2013;9():273-82. PMID: 23761972", "BibTeX": "@article{23761972, title={Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin}, author={Steinberg H and Anderson MS and Musliner T and Hanson ME and Engel SS}, journal={Vasc Health Risk Manag}, volume={9}, pages={273-82}}"}}, {"_id": "29207644", "pmid": 29207644, "pmcid": "PMC5710924", "title": "Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes", "journal": "Oncotarget", "authors": ["Lv ZH", "Phuong TA", "Jin SJ", "Li XX", "Xu M"], "date": "2017-08-24T00:00:00Z", "doi": "10.18632/oncotarget.20443", "meta_date_publication": "2017 Oct 31", "meta_volume": "8", "meta_issue": "53", "meta_pages": "91291-91305", "score": 50067.625, "text_hl": "Protection by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@-induced @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ through inhibiting @GENE_DFNA34 @GENE_114548 @@@NLRP3@@@ inflammasomes", "citations": {"NLM": "Lv ZH, Phuong TA, Jin SJ, Li XX, Xu M. Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes Oncotarget. 2017 Oct 31;8(53):91291-91305. PMID: 29207644", "BibTeX": "@article{29207644, title={Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes}, author={Lv ZH and Phuong TA and Jin SJ and Li XX and Xu M}, journal={Oncotarget}, volume={8}, number={53}, pages={91291-91305}}"}}, {"_id": "29138670", "pmid": 29138670, "pmcid": "PMC5613468", "title": "Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats", "journal": "Oxid Med Cell Longev", "authors": ["Al-Rasheed NM", "Al-Rasheed NM", "Hasan IH", "Al-Amin MA", "Al-Ajmi HN", "Mohamad RA", "Mahmoud AM"], "date": "2017-01-01T00:00:00Z", "doi": "10.1155/2017/1092015", "meta_date_publication": "2017", "meta_volume": "2017", "meta_issue": "", "meta_pages": "1092015", "score": 50060.89, "text_hl": "...3.2. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Prevents @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@Hyperglycemia@@@-Induced Damage and Collagen Deposition in the @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic Heart@@@", "citations": {"NLM": "Al-Rasheed NM, Al-Rasheed NM, Hasan IH, Al-Amin MA, Al-Ajmi HN, Mohamad RA, Mahmoud AM. Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats Oxid Med Cell Longev. 2017;2017():1092015. PMID: 29138670", "BibTeX": "@article{29138670, title={Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats}, author={Al-Rasheed NM and Al-Rasheed NM and Hasan IH and Al-Amin MA and Al-Ajmi HN and Mohamad RA and Mahmoud AM}, journal={Oxid Med Cell Longev}, volume={2017}, pages={1092015}}"}}, {"_id": "29732238", "pmid": 29732238, "title": "Pharmacometabolomic signature links simvastatin therapy and insulin resistance.", "journal": "Metabolomics", "authors": ["Elbadawi-Sidhu M", "Baillie RA", "Zhu H", "Chen YI", "Goodarzi MO", "Rotter JI", "Krauss RM", "Fiehn O", "Kaddurah-Daouk R"], "date": "2017-01-01T00:00:00Z", "doi": "10.1007/s11306-016-1141-3", "meta_date_publication": "2017 Jan", "meta_volume": "13", "meta_issue": "", "meta_pages": "", "score": 50059.61, "text_hl": "Results: Six weeks of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment resulted in 6.9% of @SPECIES_9606 @@@patients@@@ developing @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and 25% developing changes consistent with development of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@pre-diabetes@@@. ", "citations": {"NLM": "Elbadawi-Sidhu M, Baillie RA, Zhu H, Chen YI, Goodarzi MO, Rotter JI, Krauss RM, Fiehn O, Kaddurah-Daouk R. Pharmacometabolomic signature links simvastatin therapy and insulin resistance. Metabolomics. 2017 Jan;13():. PMID: 29732238", "BibTeX": "@article{29732238, title={Pharmacometabolomic signature links simvastatin therapy and insulin resistance.}, author={Elbadawi-Sidhu M and Baillie RA and Zhu H and Chen YI and Goodarzi MO and Rotter JI and Krauss RM and Fiehn O and Kaddurah-Daouk R}, journal={Metabolomics}, volume={13}}"}}, {"_id": "23671864", "pmid": 23671864, "pmcid": "PMC3647597", "title": "The Effect of Simvastatin on Glucose Homeostasis in Streptozotocin Induced Type 2 Diabetic Rats", "journal": "J Diabetes Res", "authors": ["Wang L", "Duan G", "Lu Y", "Pang S", "Huang X", "Jiang Q", "Dang N"], "date": "2013-01-01T00:00:00Z", "doi": "10.1155/2013/274986", "meta_date_publication": "2013", "meta_volume": "2013", "meta_issue": "", "meta_pages": "274986", "score": 50057.438, "text_hl": "These data indicate that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ intervention @SPECIES_10116 @@@rats@@@ may cause @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ by impairing the function of islet beta cells and have an adverse effect on @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ homeostasis, especially on FPG level.", "citations": {"NLM": "Wang L, Duan G, Lu Y, Pang S, Huang X, Jiang Q, Dang N. The Effect of Simvastatin on Glucose Homeostasis in Streptozotocin Induced Type 2 Diabetic Rats J Diabetes Res. 2013;2013():274986. PMID: 23671864", "BibTeX": "@article{23671864, title={The Effect of Simvastatin on Glucose Homeostasis in Streptozotocin Induced Type 2 Diabetic Rats}, author={Wang L and Duan G and Lu Y and Pang S and Huang X and Jiang Q and Dang N}, journal={J Diabetes Res}, volume={2013}, pages={274986}}"}}, {"_id": "19205554", "pmid": 19205554, "title": "Vascular reactivity in the experimental, simvastatin-treated diabetes with endothelial dysfunction.", "journal": "Bratisl Lek Listy", "authors": ["Yalcin S", "Köksoy C", "Ergül E", "Demirel E", "Yalcin B"], "date": "2008-01-01T00:00:00Z", "meta_date_publication": "2008", "meta_volume": "109", "meta_issue": "11", "meta_pages": "477-82", "score": 50054.324, "text_hl": "RESULTS: We observed that @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight-loss@@@ observed in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@ were partially treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, but were still different from the control group. ", "citations": {"NLM": "Yalcin S, Köksoy C, Ergül E, Demirel E, Yalcin B. Vascular reactivity in the experimental, simvastatin-treated diabetes with endothelial dysfunction. Bratisl Lek Listy. 2008;109(11):477-82. PMID: 19205554", "BibTeX": "@article{19205554, title={Vascular reactivity in the experimental, simvastatin-treated diabetes with endothelial dysfunction.}, author={Yalcin S and Köksoy C and Ergül E and Demirel E and Yalcin B}, journal={Bratisl Lek Listy}, volume={109}, number={11}, pages={477-82}}"}}, {"_id": "31217552", "pmid": 31217552, "pmcid": "PMC6584635", "title": "Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model", "journal": "Sci Rep", "authors": ["Seshadri S", "Rapaka N", "Prajapati B", "Mandaliya D", "Patel S", "Muggalla CS", "Kapadia B", "Babu PP", "Misra P", "Saxena U"], "date": "2019-06-19T00:00:00Z", "doi": "10.1038/s41598-019-45369-8", "meta_date_publication": "2019 Jun 19", "meta_volume": "9", "meta_issue": "1", "meta_pages": "8825", "score": 50053.11, "text_hl": "Here, we treated @DISEASE_Sucrase_isomaltase_deficiency_congenital @DISEASE_MESH:C538139 @@@HSD@@@ fed @SPECIES_10116 @@@rats@@@ with high dose statins using @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ (20 mg/kg) and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (30 mg/kg) for a shorter duration (30 days) to push hard on the prospect of statins worsening @<m>DISEASE_Hyperglycemia</m> @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @GENE_INS @GENE_3630 @@@insulin@@@ signaling. ", "citations": {"NLM": "Seshadri S, Rapaka N, Prajapati B, Mandaliya D, Patel S, Muggalla CS, Kapadia B, Babu PP, Misra P, Saxena U. Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model Sci Rep. 2019 Jun 19;9(1):8825. PMID: 31217552", "BibTeX": "@article{31217552, title={Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model}, author={Seshadri S and Rapaka N and Prajapati B and Mandaliya D and Patel S and Muggalla CS and Kapadia B and Babu PP and Misra P and Saxena U}, journal={Sci Rep}, volume={9}, number={1}, pages={8825}}"}}]}